EN
HI
Summary
As of 13 Nov, 2026, Colinz Laboratories stock price is ₹70. During the trading session, the stock has moved between an intraday low of ₹69.00 and an intraday high of ₹70.00. Over the last 52 weeks, Colinz Laboratories has traded between ₹36.11 and ₹87.91.
The stock has recorded a trading volume of 1,259 shares,. Its Average Traded Price (ATP) is ₹69.92, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 6 @ ₹70.00.
Colinz Laboratories has an upper circuit limit of ₹73.15 and a lower circuit limit of ₹59.85. The total value traded stands at ₹88029.28, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Colinz Laboratories also offers a dividend yield of 0%.
Colinz Laboratories Share Price Chart
Colinz Laboratories Share Key Metrics
Volume
1259.00
Market Cap
17.63 CR
LTQ@LTP
6@70.00
ATP
69.92
Var Margin
29.72 %
Circuit Range
59.85-73.15
Delivery %
0 %
Value
88029.28
ASM/GSM
No
Market Lot
1
Colinz Laboratories Resistance and Support
Pivot 67.5
Resistance
First Resistance
68.5
Second Resistance
70.5
Third Resistance
71.5
Support
First Support
65.5
Second Support
64.5
Third Support
62.5
Colinz Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Nov 12 2026 | 69 | 70 | 5.26% | 70 | 69 |
| Wed Nov 11 2026 | 69.5 | 66.5 | -5.00% | 69.5 | 66.5 |
| Mon Nov 09 2026 | 70.37 | 70 | 1.48% | 70.37 | 67.59 |
Colinz Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-29 | Quarterly Results |
| 2026-07-30 | Quarterly Results |
| 2026-04-29 | Quarterly Results |
| 2026-01-24 | Quarterly Results |
| 2026-01-17 | Others |
| 2025-11-27 | Others |
| 2025-11-11 | Others |
| 2025-11-03 | Quarterly Results |
| 2025-07-31 | Quarterly Results |
| 2025-05-16 | Audited Results |
| 2025-01-31 | Quarterly Results |
| 2024-10-30 | Quarterly Results |
| 2024-08-08 | Others |
Colinz Laboratories News
Colinz Laboratories Ltd - 531210 - Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Colinz Laboratories announced its Q2 FY27 financial results. The company reported revenue of ₹1.55 crores, up 11.7% YoY, while net profit declined 10% YoY to ₹0.13 crores. For the half-year period, net profit stood at ₹2.52 crores.
Oct 29 2026 17:33:45
Colinz Laboratories Ltd - 531210 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Colinz Laboratories board to meet on 29 Oct 2026 for financial results. The primary agenda is to consider results for the quarter and half year ended Sep 2026.
Oct 19 2026 17:55:15
Colinz Laboratories Management
| Name | Position |
|---|---|
| Falguni Kumawat | Company Secretary & Compliance Officer |
| N K Menon | Whole Time Director |
Colinz Laboratories Similar Stocks
Beryl Drugs Ltd.
24.00
-1.34 (5.29%)
Sharma East India Hospitals & Medical Research Ltd
80.20
-0.03 (0.04%)
Norris Medicines Ltd.
14.26
-0.24 (1.66%)
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Parmax Pharma Ltd.
135.00
0.00 (0.00%)
Broach Lifecare Hospital Ltd.
12.70
0.00 (0.00%)
Starsource Multitrade Ltd.
101.20
-5.30 (4.98%)
Unjha Formulations Ltd.
28.20
-0.05 (0.18%)
Hindustan Bio Sciences Ltd.
7.00
0.20 (2.94%)
Colinz Laboratories FAQs
The Buying Price of Colinz Laboratories share is 70 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Colinz Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Colinz Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Colinz Laboratories shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Colinz Laboratories shares is 0. Useful to assess the stock's value relative to its book value.
To assess Colinz Laboratories’s valuation compare Sector P/E, P/B which are 41.06 & 3.86 with sector averages, along with growth rates and financial metrics.
The Market Cap of Colinz Laboratories is 17.63 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Colinz Laboratories share price is 87.91 & 36.11. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Colinz Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in COLINZ
